Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY4R | P50391 | 16/20 | 0.61 |
| ▸ | NPY1R | P25929 | 10/20 | 0.61 |
| ▸ | NPY5R | Q15761 | 8/20 | 0.61 |
| ▸ | NPY2R | P49146 | 6/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27639946 | 1.00 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2RALDH1A1 | |
| SCHEMBL29947104 | 1.00 | NPY4R (0.61) | NPY4RNPY1RNPY5RNPY2RALDH1A1 | |
| SCHEMBL30958046 | 0.97 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2RALDH1A1 | |
| SCHEMBL29794924 | 0.97 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2RALDH1A1 | |
| SCHEMBL3138312 | 0.97 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2RALDH1A1 | |
| SCHEMBL3138301 | 0.97 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2RALDH1A1 | |
| SCHEMBL29531992 | 0.97 | NPY4R (0.58) | NPY4RNPY1RNPY5RNPY2RALDH1A1 | |
| SCHEMBL30647286 | 0.96 | NPY4R (0.63) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL29947085 | 0.96 | NPY4R (0.63) | NPY4RNPY1RNPY5RNPY2R | |
| SCHEMBL31601685 | 0.96 | NPY4R (0.63) | NPY4RNPY1RNPY5RNPY2RKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117466974-A | Antimicrobial peptide and application thereof | 中国药科大学 | 2024-01-30 | — | — | CN | claimed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| CN-117466974-B | Antimicrobial peptide and application thereof | 中国药科大学 | 2024-03-26 | — | — | CN | disclosed |
| CN-117466974-A | Antimicrobial peptide and application thereof | 中国药科大学 | 2024-01-30 | — | — | CN | disclosed |
| US-11758933-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2023-09-19 | — | — | US | disclosed |
| CN-109942714-B | Functional polypeptide and application | 中国药科大学 | 2022-07-08 | — | — | CN | disclosed |
| EP-3368542-B1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2022-06-22 | — | — | EP | disclosed |
| US-11357246-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2022-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | NPY4R 1026/4885NPY1R 920/4885NPY5R 1220/4885 |
| US-11357246-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | NPY4R 1026/4885NPY1R 920/4885NPY5R 1220/4885 |
| US-11758933-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | NPY4R 1026/4885NPY1R 920/4885NPY5R 1220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.